ULK1 and metabolic dysfunction-associated steatotic liver disease: KSJG granules demonstrates a “treat different diseases together” therapeutic potential, effectively improving OP through AMPK/ULK1 autophagy pathway activation while regulating hepatic lipid metabolism to alleviate NAFLD.